SkylineDx is a commercial-stage company dedicated to the development and commercialization of innovative gene signature-based diagnostic tests. These tests are designed to assist healthcare professionals in making personalized treatment decisions by accurately determining the type or status of a disease and predicting a patient's response to specific treatments. By providing detailed insights into individual patient profiles, SkylineDx's technology enables tailored treatment approaches, enhancing the potential for effective healthcare outcomes.
DCPrime is a clinical-stage cancer immunotherapy company, which develops therapeutic vaccines based on its proprietary DCOne platform. DCOne‐based vaccines share all immune‐stimulatory properties with patient-derived dendritic cell‐based vaccines, and have the simple logistics of off‐the‐shelf products. DCOne cells express a range of known tumor antigens, which are targeted in several cancer types.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.